Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, December 24 through Wednesday, December 26 inclusive. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Advertisement

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 22.09.17 in Vol 3, No 1 (2017): CHC Issue

This paper is in the following e-collection/theme issue:

    Abstract

    Continuous Remote Monitoring of Vital Signs in Pediatric Population

    VitalConnect Inc., San Jose, CA, United States

    Corresponding Author:

    Dhwanil Damania, PhD (Biom Eng)

    VitalConnect Inc.

    224

    Airport Parkway

    San Jose, CA, 95110

    United States

    Phone: (408) 963 4600

    Email:


    ABSTRACT

    Background: Wearable sensor technologies coupled with secure patient portals allow for continuous real-time data acquisition from a patient in a hospital or home setting. This combination renders more effective health-management system with faster patient-recovery times and reduced healthcare costs. VitalConnect Inc. has developed a fully-disposable, FDA-cleared (for adults) wireless biosensor (VitalPatch®) that is worn on chest. VitalPatch captures multiple medical-grade biometrics and transmits the physiological data continuously (via Bluetooth) for up to 96 hours to a relay (tablet, wireless hub). Like adults, pediatric patients (5-17 years of age) could also benefit from such small and low-profile biosensor that can collect and stream vital signs uninterruptedly to a secure patient-portal. This data can then be monitored by a clinical triage center or healthcare-provider.

    Objective: Continuous remote monitoring of heart rate (HR) and breathing rate (BR) is critical during acute or chronic illnesses. The primary purpose of this study was to evaluate the performance of the VitalConnect platform in pediatric subjects during activities of daily living (ADL) to confirm accuracy of sensor measurements for HR and BR with respect to a clinical reference device, Capnostream20 (Oridion). Additionally, information on comfort and usability of VitalPatch at home was assessed for the total duration of wear.

    Methods: Thirty-five children were enrolled in the study (24 between 9-17 years, 11 between 5-8 years). All subjects participated in 96-hour wear-period of the VitalPatch biosensor and performed one hour of in-lab protocol on Day1 of the wear duration. Each participant underwent stationary breathing exercises (spontaneous, metronome), ADLs with postural maneuvers and treadmill walking. The study was conducted in presence of a nurse after approval from Institutional Review Board. The performance of heart rate, respiration rate, posture and number of steps were assessed for each subject separately using the mean absolute error (MAE) between the true and measured values. The reference for posture and step count was manual observation.

    Results: During the stationary condition, MAE (across 35 children) for HR and BR was 2.1±1.0 beats per minute (BPM) and 2.2±0.8 breaths per minute (BrPM) respectively compared to Capnostream20. During ADLs, MAE was 4.3±2.7 BPM for HR and 3.7±1.7 BrPM for BR. Accuracy of posture (standing, supine, walking) was >93% and step-count was >95% overall. Moreover, 80% participants rated wearing VitalPatch ‘comfortable’ without any itchiness during 96-hour wear.

    Conclusions: The VitalPatch biosensor demonstrated clinically-acceptable accuracy compared to a standardized reference device for both heart rate and breathing rate. It also provided sufficiently accurate measures for activity in terms of posture and number of steps. Furthermore, when used for up to 4 days at home, there were no adverse events (i.e. rashes, dermatitis, mechanical skin injury) and user experience was satisfactory. The accuracy of vitals and ease-of-use in the home environment in children aged 5-17 illustrate the potential of VitalPatch as a non-invasive and cost-effective vital sign monitoring alternative. VitalPatch biosensor can be integrated into state-of-art devices to monitor vital signs for pediatric patients with diseases like congenital heart abnormalities and adolescent fatigue.

    iproc 2017;3(1):e5

    doi:10.2196/iproc.8295


    Edited by T Hale; This is a non-peer-reviewed article. submitted 23.06.17; accepted 22.08.17; published 22.09.17

    ©Dhwanil Damania. Originally published in Iproceedings (http://www.iproc.org), 22.09.2017.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in Iproceedings, is properly cited. The complete bibliographic information, a link to the original publication on http://www.iproc.org/, as well as this copyright and license information must be included.